You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Dolutegravir-based ART for HIV patients at secondary care hospitals in Kwara-Central Nigeria
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-PPR-071
- By: WILLIAMS, Felicia (University of Ilorin, Clinical Pharmacy and Pharmacy Pracitice, Nigeria)
- Co-author(s): Felicia Esemekiphoraro Williams: Clinical Pharmacy and Pharmacy Practice, University of Ilorin, Ilorin, Nigeria
David Adje: Clinical Pharmacy and Pharmacy Administration, Delta State University, Abraka, Nigeria
Aishah Abdulkareem: Clinical Pharmacy and Pharmacy Practice, University of Ilorin, Ilorin, Nigeria - Abstract:
Background
Current guideline from World Health Organization recommends dolutegravir (DTG) an integrase strand inhibitor (INSTI) as a core component of antiretroviral therapy (ART) for first line treatment. The efficacy of DTG has been demonstrated in several randomized control trials (SINGLE, SPRING, FLAMINGO and STRIIVING). Dearth of information
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026